300 related articles for article (PubMed ID: 37422985)
1. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
[TBL] [Abstract][Full Text] [Related]
2. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
[No Abstract] [Full Text] [Related]
3. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
[TBL] [Abstract][Full Text] [Related]
4. Insights from biosurveillance: non-fatal opioid overdoses in Rhode Island 2019-21.
King E; Marchetti L; Weidele H; Wolanski J; Shrestha N; St John K; Scagos R
Addiction; 2022 Sep; 117(9):2464-2470. PubMed ID: 35434861
[TBL] [Abstract][Full Text] [Related]
5. Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study.
Aronson ID; Ardouin-Guerrier MA; Baus JE; Bennett AS
JMIR Form Res; 2024 Jul; 8():e56755. PubMed ID: 38959505
[TBL] [Abstract][Full Text] [Related]
6. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses - Eight Syringe Services Programs, Maryland, November 2021-August 2022.
Russell E; Sisco E; Thomson A; Lopes J; Rybak M; Burnett M; Heilman D; Appley MG; Gladden RM
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(17):458-462. PubMed ID: 37104171
[TBL] [Abstract][Full Text] [Related]
7. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program.
Vohra V; Stroh-Steiner GK; Jones P
Clin Toxicol (Phila); 2023 Dec; 61(12):1040-1046. PubMed ID: 38088581
[TBL] [Abstract][Full Text] [Related]
9. "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.
Collins AB; Macon EC; Levin S; Wunsch C; Wightman RS
Int J Drug Policy; 2024 May; 127():104391. PubMed ID: 38490014
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
[TBL] [Abstract][Full Text] [Related]
11. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
[TBL] [Abstract][Full Text] [Related]
13. Opioid overdoses involving xylazine in emergency department patients: a multicenter study.
Love JS; Levine M; Aldy K; Brent J; Krotulski AJ; Logan BK; Vargas-Torres C; Walton SE; Amaducci A; Calello D; Hendrickson R; Hughes A; Kurt A; Judge B; Pizon A; Schwarz E; Shulman J; Wiegan T; Wax P; Manini AF
Clin Toxicol (Phila); 2023 Mar; 61(3):173-180. PubMed ID: 37014353
[TBL] [Abstract][Full Text] [Related]
14. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
[TBL] [Abstract][Full Text] [Related]
15. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
[TBL] [Abstract][Full Text] [Related]
16. Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods.
Thompson E; Tardif J; Ujeneza M; Badea A; Green TC; McKee H; McKenzie M; Park JN
Drug Alcohol Depend Rep; 2024 Jun; 11():100241. PubMed ID: 38808200
[TBL] [Abstract][Full Text] [Related]
17. Costing analysis of a point-of-care drug checking program in Rhode Island.
Cepeda JA; Thompson E; Ujeneza M; Tardif J; Walsh T; Morales A; Rosen JG; Green TC; Park JN
Drug Alcohol Depend; 2023 Dec; 253():111028. PubMed ID: 38000322
[TBL] [Abstract][Full Text] [Related]
18. High willingness to use rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL
Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052
[TBL] [Abstract][Full Text] [Related]
19. Adulterants present in the San Diego county fentanyl supply: a laboratory analysis of seized law enforcement samples.
Galust H; Seltzer JA; Hardin JR; Friedman NA; Salamat J; Clark RF; Harmon J
BMC Public Health; 2024 Mar; 24(1):923. PubMed ID: 38553721
[TBL] [Abstract][Full Text] [Related]
20. Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study.
Park JN; Serafinski R; Ujeneza M; McKenzie M; Tardif J; Krotulski AJ; Badea A; Grossman ER; Green TC
Drug Alcohol Depend Rep; 2024 Jun; 11():100247. PubMed ID: 38974777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
